Merkliste 
 1 Ergebnisse 
 
1

Camrelizumab plus famitinib in patients with recurrent or m..:

Xi Ding ; Yi-Jun Hua ; Xiong Zou...
http://www.sciencedirect.com/science/article/pii/S2589537023002201.  , 2023